Hardware Podcasts

250 - PIC/S PI 006-4 (2026): What Changed in Qualification & Validation?

Let's Combinate · 12 Aug 2026 · 11m

What this episode covers

Subhi Saadeh, founder of Let's Combinate, analyzes the 2026 update to PIC/S PI 006-4, the first major revision to qualification and validation recommendations in nearly 20 years. He details how the document shifts from the 2007 PI 006-3 standard toward a lifecycle approach with stronger Quality Risk Management (QRM) and explicit statistical requirements for sampling and process capability. Saadeh highlights the removal of the rigid 'three-batch rule' and the clear distinction between Continuous Process Verification (CPV) for initial validation and Ongoing Process Verification (OPV) for routine manufacturing.

Most relevant to

early-stage companies

Topics

Mentioned

Companies
PIC/S, Let's Combinate
Also
PI 006-4, PI 006-3, EU Annex 15, ICH Q8, ICH Q9, ICH Q10, ICH Q11, Annex 11

Related episodes from other shows

Other shows on the same ground, closest first.

  • Global Medical Device Podcast · 19m

    #438: QMSR Mythbusters Episode

    Host Etia Nichols from Greenlight Guru explains the FDA's new Quality Management System Regulation (QMSR), which replaces 21 CFR Part 820 and incorporates ISO 13485:2016 by reference, with a mandatory enforcement date of February 2, 2026. Nichols debunks the myth that the Device Master Record (DMR), Design History File (DHF), and Device History Record (DHR) are being eliminated, clarifying they are mapped to the Medical Device File (MDF), Design and Development File (DDP), and Batch or Lot Record respectively. She highlights three critical shifts: the explicit integration of lifecycle risk management as the 'DNA' of the QMS, the loss of audit privilege making internal records inspectable, and retained US-specific requirements like UDI in complaint records and extended record retention.

    Certification & complianceQuality & yield
    1 chapters

  • Global Medical Device Podcast · 37m

    How to Leverage IEC 62304 to Improve SaMD Development Processes

    Cathy Wilburn, Director of Quality Assurance and Compliance at The RND Group, explains how to leverage the IEC 62304 standard for Software as a Medical Device (SaMD) development. She clarifies that IEC 62304 is a voluntary, recognized consensus standard that provides a framework for software lifecycle processes rather than a prescriptive waterfall methodology, allowing for agile integration. The discussion covers mapping these processes to FDA 21 CFR 820.30 design controls, using software safety classes (A, B, C) for risk management per ISO 14971, and navigating regulatory submissions for both the US (510(k)/PMA) and EU (MDR/IVDR).

    Certification & complianceEmbedded firmware
    5 chapters

  • Global Medical Device Podcast · 1h 08m

    #326 CSA vs. CSV: Modern Validation for Modern MedTech

    Sandra Rodriguez, an analyst at Axendia, discusses the FDA's shift from Computer System Validation (CSV) to Computer Software Assurance (CSA) in medical device manufacturing. She explains how CSA flips the traditional validation pyramid by prioritizing critical thinking and risk assessment over exhaustive documentation, significantly reducing the burden on companies. The conversation covers the industry's response to the September 2022 draft guidance, the role of GAMP 5, and the evolving relationship between life science companies and technology vendors like Greenlight Guru.

    Certification & complianceQuality & yield
    8 chapters

  • Global Medical Device Podcast · 37m

    #445: ISO 10993-1:2025: What Risk-Based Biocompatibility Means for MedTech

    Thor Rollins, a leader at Nelson Labs and convener of the ISO committee revising ISO 10933-1, explains the 2025 standard's shift from checkbox testing to a risk-based approach aligned with ISO 14971. He details new requirements for lifecycle evaluation, particularly for reprocessed devices, and the concept of biological equivalence to reduce redundant testing. Rollins also discusses the US's rejection of the draft due to lack of guidance, the upcoming technical specifications, and practical advice for companies at different stages of development.

    Certification & complianceMaterials & manufacturing processes
    8 chapters

  • Global Medical Device Podcast · 33m

    #474: Behind the QMSR Audits: The Top 5 FDA Citations & Risk Management Pitfalls

    Nikhil Mangale, Vice President of Quality at Kapstone Medical, discusses the real-world impact of the FDA's Quality Management System Regulation (QMSR) based on seven months of inspection data. He identifies the top five FDA citations as risk management, supplier controls, complaint handling, Unique Device Identification (UDI), and corrective actions, noting that inspectors now focus on operational processes rather than terminology updates like renaming Design History Files (DHF) to Design and Development Files (DDF). Mangale advises companies to implement a three-layer mapping strategy, prioritize risk management as a living process, and maintain open DDFs throughout the product lifecycle to avoid citations. He also clarifies that ISO 13485 certification does not exempt companies from FDA inspections and highlights the continued value of MDSAP enrollment for sites in multiple jurisdictions.

    Certification & complianceQuality & yield
    9 chapters

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Let's Combinate. The episode itself belongs to its publisher.